AbbVie
Price & Volume
Stats
See moreOpen | $230.63 |
Previous Close | $233.42 |
Day Range | $223.17-$231.42 |
52W Range | $160.33-$243.05 |
Market Cap | $395.7B |
Shares Short | 18M |
Financials
See moreRevenue (12 Mos) | $59.6B |
Revenue Growth (YoY) | 9.1% |
Gross Profit (12 Mos) | $42.6B |
Diluted EPS | $1.32 |
News
See moreYahoo Finance • 8 days ago
AbbVie (ABBV) Maintains Immunology Dominance as Analysts Downplay Competitive Threat From J&J’s Tremfya to Skyrizi Market Share
Yahoo Finance • 8 days ago
The Best High-Yield ETF to Buy for 2026: SCHD or HDV?
Yahoo Finance • 9 days ago
BofA Cuts AbbVie (ABBV) Target While Maintaining Neutral View
Yahoo Finance • 9 days ago
Investors should beware of AI's circular financing trap, look for alternatives like Broadcom
About
CEO | Mr. Robert A. Michael CPA |
CFO | Mr. Scott T. Reents |
Address | 1 North Waukegan Road, North Chicago, IL, United States, 60064-6400 |
Sector | Healthcare |
Industry | Drug Manufacturers - General |
Full-Time Employees | 55,000 |
